NCT07640334

Brief Summary

The goal of this study is to evaluate the safety of integrating the Aortic Dissection Detection Risk Score (ADD-RS) and D-dimer testing for ruling out acute aortic syndrome (AAS) in the emergency department (ED). The main question it aims to answer: Can the combination of the ADD-RS \<2, and D dimer \<500ng/mL rule-out AAS in ED patients without CTA? The researchers will recruit patients suspected with AAS in the ED, and the patients will receive a ADD-RS score, a D-dimer testing after signing a written consent.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
448

participants targeted

Target at P75+ for all trials

Timeline
30mo left

Started Jul 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 10, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

July 13, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2028

6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

June 10, 2026

Status Verified

June 1, 2026

Enrollment Period

2 years

First QC Date

June 4, 2026

Last Update Submit

June 8, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • incidence of missed AAS within 30 days among patients identified as low risk (ADD-RS <2 and D-dimer <500 ng/mL) who did not undergo CTA

    number of patients with ADD-RS \<2 and a negative D-dimer who were actually AAS cases

    From enrollment to 30 days after index visit

Secondary Outcomes (1)

  • sensitivity of the proposed algorithm

    From enrolment to 30 days after the index visit

Other Outcomes (3)

  • D-dimer levels in different subgroups

    After completion of recruitment, estimated 18 months

  • Hospital length of stay

    From enrolment to 30 day follow-up

  • proportion of patients undergoing CT imaging

    From enrolment til patient discharged from the ED, estimated within the day of enrolment

Interventions

D-dimer testDIAGNOSTIC_TEST

The patient will receive a ADD-RS calculated by the clinician, evaluating high-risk conditions, high-risk pain features and high-risk physical signs of AAS. A point-of-care D-dimer test will be performed after routine blood taking. The research personnel will collect the above data from the clinician.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients presenting to the ED meeting the above criteria during the recruitment timeframe

You may qualify if:

  • Adult patients aged ≥ 18 years; AND
  • Presentation to the ED with any of the following symptoms: acute onset (\<14 days) chest pain, abdominal pain, back pain, syncope, or signs of malperfusion (e.g. limb ischemia, neurological deficit); AND
  • AAS is considered as a possible differential diagnosis by the treating physician. Enrolment in the study will be determined by the attending physician during initial medical consultation in the ED and prior to establishing a final diagnosis.

You may not qualify if:

  • An alternative diagnosis to AAS established by the treating physician after the initial assessment; OR
  • Trauma cases; OR
  • Patients with a known diagnosis of AAS before the index ED visit (e.g. with a diagnostic imaging done before the ED visit or referral from other institutions for AAS); OR
  • Clinical severity or other conditions not allowing complete evaluation/proper enrolment; OR
  • Patient who refuse to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prince of Wales Hospital

Shatin, Hong Kong

Location

MeSH Terms

Conditions

Acute Aortic Syndrome

Condition Hierarchy (Ancestors)

Aortic DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Colin Graham, Professor

CONTACT

Rebecca Li, Miss

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 4, 2026

First Posted

June 10, 2026

Study Start (Estimated)

July 13, 2026

Primary Completion (Estimated)

June 30, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

June 10, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Data collected from this study is exclusively for our own institutional research purpose.

Locations